AB
DFTX

Amalgamated Bank’s Definium Therapeutics DFTX Stock Holding History

Amalgamated Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,957
Closed -$40K – 2352
2025
Q4 		$40K Buy
2,957
+176
+6% +$2.18K ﹤0.01% 1885
2025
Q3 		$33K Hold
2,781
– – ﹤0.01% 1959
2025
Q2 		$18K Hold
2,781
– – ﹤0.01% 2154
2025
Q1 		$16K Buy
2,781
+290
+12% +$2.08K ﹤0.01% 2159
2024
Q4 		$17K Hold
2,491
– – ﹤0.01% 2187
2024
Q3 		$14K Hold
2,491
– – ﹤0.01% 2291
2024
Q2 		$18K Buy
+2,491
New +$21.8K ﹤0.01% 2171
2022
Q2 		– Sell
-3,196
Closed -$53K – 3140
2022
Q1 		$53K Buy
+3,196
New +$55.4K ﹤0.01% 2454

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amalgamated Bank's DFTX Position: Q1 2026 in Review

Amalgamated Bank sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 2,957 shares — an estimated $40K sold.

Amalgamated Bank first reported a position in DFTX in Q1 2022 and held it in 8 quarters. The position peaked at $53K in Q1 2022. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Amalgamated Bank reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,957 Definium Therapeutics shares in Q1 2026, an estimated $40K.
  • Amalgamated Bank first reported a position in Definium Therapeutics in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Definium Therapeutics position peaked at $53K in Q1 2022.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.